What is Arvinas's cumulative cost basis?

Arvinas (ARVN) reported cumulative cost basis of $34M in Q1 2026.

How has Arvinas's cumulative cost basis changed year-over-year?

Arvinas's cumulative cost basis increased by 4.3% year-over-year, from $32.6M to $34M.

What is the long-term trend for Arvinas's cumulative cost basis?

Over 4 years (2021 to 2025), Arvinas's cumulative cost basis has grown at a 9.3% compound annual growth rate (CAGR), from $23.4M to $33.4M.

Arvinas ARVN Cumulative Cost Basis

Cumulative Cost Basis at other companies

Nurix Therapeutics, Inc.NRIX

——

Inhibrx Biosciences, Inc.INBX

——

Arcus BiosciencesRCUS

——

Nuvation BioNUVB

——

Other financials

Income statement

See full

Revenue$15.6M-91.7%

Operating income-$63.8M-189%

Net income-$57.6M-169%

EPS (diluted)-$0.90-179%

Balance sheet

See full

Cash & equivalents$87.3M+7.8%

Total debt$8.6M-19.6%

Total equity$386.8M-41.4%

Total assets$647.5M-35.3%

Cash flow

See full

Operating cash flow-$69.2M+22.2%

CapEx$1.3M+225%

Free cash flow-$70.5M+21.1%

Valuation

See full

Market cap$518.11M-4.6%

Enterprise value$439.41M-7.1%

P/S5.8×+4.5×

Profitability

See full

Operating margin-283.8%-310pp

Net margin-247.5%-260pp

FCF margin-287.4%—

Returns & leverage

See full

Return on equity-42.3%-53.5pp

Debt / equity0×0.0×

Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arvinas's cumulative cost basis?: Arvinas (ARVN) reported cumulative cost basis of $34M in Q1 2026.
How has Arvinas's cumulative cost basis changed year-over-year?: Arvinas's cumulative cost basis increased by 4.3% year-over-year, from $32.6M to $34M.
What is the long-term trend for Arvinas's cumulative cost basis?: Over 4 years (2021 to 2025), Arvinas's cumulative cost basis has grown at a 9.3% compound annual growth rate (CAGR), from $23.4M to $33.4M.